Clinical Trials Browser

Completed × sacituzumab govitecan × 90 days × Clear all

NCT04527991 2026-06-02

TROPiCS-04

Phase 3 Completed

711 enrolled 25 charts

Locally Advanced or Metastatic Unresectable Urothelial Cancer

NCT05226117 2026-03-27

Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer

Phase 2 Completed

Carcinoma, Transitional Cell